메뉴 건너뛰기




Volumn 86, Issue , 2014, Pages 318-334

Novel hybrids of metronidazole and quinolones: Synthesis, bioactive evaluation, cytotoxicity, preliminary antimicrobial mechanism and effect of metal ions on their transportation by human serum albumin

Author keywords

Antibacterial; DNA; HSA; Imidazole; Metronidazole; Quinolone

Indexed keywords

HUMAN SERUM ALBUMIN; METAL ION; METRONIDAZOLE; QUINOLONE DERIVATIVE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CHLOROMYCIN; ETHYL 1 (OXIRAN 2 YLMETHYL) 4 OXO 7 (TRIFLUOROMETHYL) 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 1 [2 HYDROXY 3 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPYL] 4 OXO 6 (TRIFLUOROMETHYL) 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 1 [2 HYDROXY 3 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPYL] 6 METHYL 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 1 [2 HYDROXY 3 (4 NITRO 1H IMIDAZOL 1 YL)PROPYL] 4 OXO 7 (TRIFLUOROMETHYL) 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 1 [2 HYDROXY 3 (4 NITRO 1H IMIDAZOL 1 YL)PROPYL] 6 METHYL 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 6 FLUORO 1 (OXIRAN 2 YLMETHYL) 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 6 FLUORO 1 [2 HYDROXY 3 (4 NITRO 1H IMIDAZOL 1 YL)PROPYL] 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 6 FLUORO1 [2 HYDROXY 3 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPYL] 4 OXO 1,4 DIHYROQUINOLINE 3 CARBOXYLATE; ETHYL 6 METHOXY 1 (OXIRAN 2 YLMETHYL) 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 6 METHYL 1 (OXIRAN 2 YLMETHYL) 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 6,8 DI FLUORO 1 [2 HYDROXY 3 (4 NITRO 1H IMIDAZOL 1 YL)PROPYL] 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 6,8 DICHLORO 1 (OXIRAN 2 YLMETHYL) 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 6,8 DICHLORO 1 [2 HYDROXY 3 (4 NITRO 1H IMIDAZOL 1 YL)PROPYL] 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 6,8 DIFLUORO 1 (OXIRAN 2 YLMETHYL) 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 6,8 DIFLUORO 1 [2 HYDROXY 3 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPYL] 4 OXO 1,4 DIHYROQUINOLINE 3 CARBOXYLATE; ETHYL 7 CHLORO 1 [2 HYDROXY 3 (4 NITRO 1H IMIDAZOL 1 YL)PROPYL] 6 METHOXY 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 7 CHLORO 6 FLUORO 1 (OXIRAN 2 YLMETHYL) 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 7 CHLORO 6 FLUORO1 [2 HYDROXY 3 (4 NITRO 1H IMIDAZOL 1 YL)PROPYL] 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 8 FLUORO 1 (OXIRAN 2 YLMETHYL) 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; ETHYL 8 FLUORO 1 [2 HYDROXY 3 (4 NITRO 1H IMIDAZOL 1 YL)PROPYL] 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLATE; FLUCONAZOLE; NORFLOXACIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIINFECTIVE AGENT; CALF THYMUS DNA; DNA; ION; MAGNESIUM; SERUM ALBUMIN;

EID: 84906836140     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2014.08.063     Document Type: Article
Times cited : (105)

References (43)
  • 29
    • 0003443227 scopus 로고    scopus 로고
    • National Committee For Clinical Laboratory Standards Approved Standard Document National Committee for Clinical Laboratory Standards Wayne, PA
    • National Committee for Clinical Laboratory Standards Approved Standard Document M27-A2, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts 2002 National Committee for Clinical Laboratory Standards Wayne, PA
    • (2002) M27-A2, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.